The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
Abstract
OBJECTIVE: The aim of this study was to determine the efficacy and safety of dialectical behavior therapy plus olanzapine compared with dialectical behavior therapy plus placebo in patients with borderline personality disorder. METHOD: Sixty patients with borderline personality disorder were included in a 12-week, double-blind, placebo-controlled study. All patients received dialectical behavior therapy and were randomly assigned to receive either olanzapine or placebo following a 1-month baseline period. RESULTS: Seventy percent of the patients completed the 4-month trial. Combined treatment showed an overall improvement in most symptoms studied in both groups. Olanzapine was associated with a statistically significant improvement over placebo in depression, anxiety, and impulsivity/aggressive behavior. The mean dose of olanzapine was 8.83 mg/day. CONCLUSIONS: A combined psychotherapeutic plus pharmacological approach appears to lower dropout rates and constitutes an effective treatment for borderline personality disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the pharmacotherapy review (Stoffers 2010) included three trials testing psychotherapy plus drug against psychotherapy plus placebo (Simpson 2004;Soler 2005;Linehan 2008).”
From Psychological therapies for people with borderline personality disorder. (2012) · cites this paper as Soler 2005
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Oldham, J. M. (2005) · Focus · doi:10.1176/foc.3.3.396 · Cited by 429
Dialectical behavior therapy: Current status, recent developments, and future directions
Robins, C. J., & Chapman, A. L. (2004) · Journal of Personality Disorders · doi:10.1521/pedi.18.1.73.32771 · Cited by 275
Olanzapine Treatment of Female Borderline Personality Disorder Patients
Zanarini, M. C., & Frankenburg, F. R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1103 · Cited by 251
Olanzapine Versus Placebo in the Treatment of Borderline Personality Disorder
Bogenschutz, M. P., & Nurnberg, H. G. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0118 · Cited by 168
Flagged first, then by citations
Research works printed but not linked: 1
- Barrachina J, Soler J, Campins MJ, Tejero A, Pascual JC, Alvarez E, Zanarini MC, Perez Sola V: Validation of a Spanish version of the Diagnostic Interview for Borderlines—Revised (DIB-R). Actas Esp Psiquiatr 2004; 32:293–298
Cited by
Sorted by citations
Items 101–200 of 224
Pharmacotherapy of severe personality disorders: a critical review
Rinne, T., & Ingenhoven, T. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544439.010 · Cited by 9
Evaluating treatments of borderline personality disorder
Biskin, R. S., & Paris, J. (2012) · Clinical Practice · doi:10.2217/cpr.12.35 · Cited by 9
Ribeiro, J. P., Juul, S., Kongerslev, M., Jørgensen, M. S., Vӧllm, B., Edemann-Callesen, H., Sales, C. P., Schaug, J. P., Lieb, K., Simonsen, E. H., et al. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.172 · Cited by 10
Second-generation antipsychotic use in borderline personality disorder: What are we targeting?
Wasylyshen, A., & WILLIAMS, A. M. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.03.82 · Cited by 8
Broadbear, J. H., Nesci, J. B., Thomas, R. A., Thompson, K. N., Beatson, J. A., & Rao, S. (2016) · Australasian Psychiatry · doi:10.1177/1039856216654391 · Cited by 8
Pharmacological and other biological treatments of suicidal individuals
Möller, H. (2009) · doi:10.1093/med/9780198570059.003.0054 · Cited by 8
Washburn, M., Rubin, A., & Zhou, S. (2016) · Research on Social Work Practice · doi:10.1177/1049731516659363 · Cited by 9
Álvarez, I., Soler, J., Schmidt, C., & Pascual, J. C. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111623 · Cited by 7
Self-citationFoti, M., Geller, J., Guy, L., Gunderson, J., Palmer, B. A., & Smith, L. M. (2011) · Psychiatric quarterly · doi:10.1007/s11126-010-9154-y · Cited by 6
Pharmacotherapy of personality disorders: what we know and what we have to search for
Bozzatello, P., Ghirardini, C., Uscinska, M., Rocca, P., & Bellino, S. (2017) · Future Neurology · doi:10.2217/fnl-2017-0010 · Cited by 7
Hill, J. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch67 · Cited by 7
Evidence-based pharmacotherapy of personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.015 · Cited by 6
Recent approaches to pharmacotherapy of personality disorders
Bellino, S., Rinaldi, C., Bozzatello, P., & Bogetto, F. (2011) · Neuropsychiatry · doi:10.2217/npy.11.17 · Cited by 6
Behandlung der Borderline-Persönlichkeitsstörung mit atypischen Antipsychotika
Mobascher, A., Mobascher, J., Schmahl, C. G., & Malevani, J. (2007) · Der Nervenarzt · doi:10.1007/s00115-006-2243-3 · Cited by 6
Wöckel, L., Goth, K., Matic, N., Zepf, F. D., Holtmann, M. H., & Poustka, F. (2009) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.a000005 · Cited by 6
Black, D., Allen, J., McCormick, B., & Blum, N. (2011) · Personality and Mental Health · doi:10.1002/pmh.167 · Cited by 6
Pharmakologische und psycho- therapeutische Behandlung der Borderline-Störung
Remmel, A., & Bohus, M. (2006) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.54.3.185 · Cited by 9
Combined Medication and Dialectical Behavior Therapy for Borderline Personality Disorder
Schulz, S. C., & Rafferty, M. P. (2008) · Social Work in Mental Health · doi:10.1300/j200v06n01_11 · Cited by 6
Willems, A. E., Tenback, D. E., Ingenhoven, T., & van Harten, P. N. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000152 · Cited by 5
García‐Palacios, A., Haro, M. V. N., Guillén, V., Marco, J. H., & Botella, C. (2010) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 5
Kombination von Psychotherapie und Psychopharmakotherapie
Herpertz, S. C., & Mundt, C. (2008) · Elsevier eBooks · doi:10.1016/b978-343723730-0.50010-0 · Cited by 5
Borderline personality disorder: treatment approaches and perspectives
Nelson, K. J., Zagoloff, A. D., Quinn, S., Swanson, H., Garber, C., & Schulz, S. C. (2014) · Clinical Practice · doi:10.2217/cpr.14.24 · Cited by 5
Pharmacotherapy of Borderline Personality Disorder
Webber, M. A., & Farrell, J. M. (2008) · Psychopharm Review · doi:10.1097/01.idt.0000338579.72194.97 · Cited by 5
Reduction in self‐harming behaviour after zuclopenthixol decanoate
Javed, Q., Chorghade, A., Javed, S., & Pervez, Y. (2014) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.340 · Cited by 4
Psicoterapiagenética: ¿influyen los genes en la adherencia a la psicoterapia?
Pérez, V., Pascual, J. C., Soler, J., Tiana, T., Cortés, A., Baiget, M., Martín‐Blanco, A., & Álvarez, E. (2010) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2010.03.003 · Cited by 4
Self-citationCorcos, M., & Pham‐Scottez, A. (2008) · L Encéphale · doi:10.1016/s0013-7006(08)75517-9 · Cited by 4
Pharmakologische Behandlung von Borderline-Persönlichkeitsstörungen
Lieb, K., Stoffers-Winterling, J. M., & Dulz, B. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627733 · Cited by 4
Persönlichkeitsstörungen – Diagnostische Konzepte – Neurobiologie-Pharmakotherapie
Kapfhammer, H. (2008) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-008-0004-6 · Cited by 4
Recognition and management of auditory verbal hallucinations in borderline personality disorder
Niemantsverdriet, M. B. A., Slotema, C. W., Franken, I. H. A., Brandsma, J., Verbraak, M. J. P. M., Deen, M. L., Blom, J. D., & van der Gaag, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1511280 · Cited by 3
Marco, J. H., García‐Palacios, A., Navarro, M. V., & Botella, C. (2012) · REVISTA ARGENTINA DE CLINICA PSICOLOGICA · Cited by 3
Polypharmazie in der Behandlung von Persönlichkeits-und Verhaltensstörungen
Habermeyer, V., & Habermeyer, E. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_5 · Cited by 3
Borderline-Persönlichkeitsstörungen (ICD-10 F6)
Bohus, M., & Lieb, K. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50022-8 · Cited by 3
Psychotherapygenetic: Do Genes Influence Psychotherapy Adherence?
Pérez, V., Pascual, J. C., Soler, J., Tiana, T., Cortés, A., Baiget, M., Martín‐Blanco, A., & Álvarez, E. (2010) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(10)70012-1 · Cited by 3
Self-citationPharmacothérapie des troubles de la personnalité
Pélissolo, A., & Jost, F. (2011) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2011.09.001 · Cited by 3
Dialectical behaviour therapy for suicidal individual
Stanley, B., & Brodsky, B. S. (2009) · doi:10.1093/med/9780198570059.003.0057 · Cited by 3
DBT and Treatment Engagement in the Context of Highly Suicidal Complex Clients
Lindenboim, N., Lungu, A., & Linehan, M. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-49206-3_4 · Cited by 3
Dialectical behaviour therapy for suicidal individuals
Brodsky, B. S., Stanley, B., & Gratch, I. (2021) · doi:10.1093/med/9780198834441.003.0057 · Cited by 3
Farmacotherapie persoonlijkheidsstoornissen
Ingenhoven, T., & Rinne, T. (2017) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0931-3_20 · Cited by 3
Zhang, Y., Chen, S. X., Smit, M., & Chapman, A. L. (2025) · Personality and Mental Health · doi:10.1002/pmh.70034 · Cited by 3
Scala, M., Fanelli, G., Fabbri, C., & Serretti, A. (2025) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2025.2560357 · Cited by 2
Almost all antipsychotics result in weight gain: A meta-analysis
Bak, M. (2016) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.c1.039 · Cited by 2
Herpertz, S. C., & Bronisch, T. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_79 · Cited by 3
Trauma infantil e Transtorno de Personalidade Borderline : uma revisão integrativa da literatura
Freire, J. V. C., Cerqueira, A. C., Moreira, B. S., Glustak, M. E., & Cal, S. F. (2024) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085-2023-0021 · Cited by 3
Ingenhoven, T., & Rinne, T. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6821-1_19 · Cited by 2
Evidence-Based Pharmacotherapy for Personality Disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.225 · Cited by 2
Marin, L. K., Kapil-Pair, K. N., Harris, R. E., & Goodman, M. S. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0124-y · Cited by 2
Schmeck, K., & Romanos, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_20 · Cited by 2
Chapter 4. Personality Disorders
Silk, K. R., & Jibson, M. D. (2010) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378074.lg04 · Cited by 2
Nurnberg, H. G. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11com06844 · Cited by 2
Black, D. W., Paris, J., & Schulz, C. S. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch7 · Cited by 2
Mindfulness-Based Therapies for Psychological Health Conditions: A Meta-Analysis
McCarney, R. (2010) · University of Hertfordshire Research Archive (University of Hertfordshire) · Cited by 2
Pharmacology of Personality Disorders
Triebwasser, J., & Siever, L. J. (2006) · Cited by 2
Mood Stabilizers and Novel Antipsychotics in the Treatment of Borderline Personality Disorder
Bellino, S., Paradiso, E., & Bogetto, F. (2006) · Institutional Research Information System University of Turin (University of Turin) · Cited by 2
Herpertz, S. C. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_50 · Cited by 2
Chapter 20. Personality Disorders
Skodol, A. E., & Gunderson, J. G. (2012) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378333.lg20 · Cited by 1
Durpoix, A., Blay, M., Moog, C. R., Rolling, J., Weiner, L., Lalanne, L., & Weibel, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120199 · Cited by 1
Gérolymos, C., Garosi, A., Boyer, L., Yon, D. K., Rahmati, M., Gavaudan, M., & Fond, G. B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03451-4 · Cited by 1
Li, Y., & Mao, W. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117055 · Cited by 1
Overview of the treatment for borderline personality
Veerasamy, K., & Guruvaiah, L. (2013) · Sri Lanka Journal of Psychiatry · doi:10.4038/sljpsyc.v4i2.5698 · Cited by 1
Gabbard, G. O., Schmahl, C. G., Siever, L. J., & Iskander, E. G. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00027-9 · Cited by 1
Herpertz, S. C., & Bronisch, T. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_79-1 · Cited by 1
Silk, K. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5_11 · Cited by 1
Schmeck, K., & Romanos, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_21 · Cited by 1
Rostamzadeh, M., Husseini, A. A., & Mosier, W. A. (2024) · Journal of Public Health and Primary Care · doi:10.4103/jphpc.jphpc_10_24 · Cited by 1
Zamani, N., Jahangir, A. H., Noohi, S., & Teimouri, N. N. (2016) · Health Research Journal · doi:10.18869/acadpub.hrjbaq.1.3.161 · Cited by 1
La terapia dialéctico comportamenta= Dialectical behavior therapy /
Palacios, A. G. (2006) · Edupsykhé Revista de Psicología y Educación · doi:10.57087/edupsykhe.v5i2.3785 · Cited by 1
Perseius, K. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
THE ADDICTION SEVERITY INDEX MULTIMEDIA VERSION
Budman, S. H., Butler, S. F., & Villapiano, A. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088520-6.50008-1 · Cited by 1
Borderline-Persönlichkeitsstörungen (ICD-10 F6)
Bohus, M., & Lieb, K. (2007) · Elsevier eBooks · doi:10.1016/b978-343724131-4.50021-4 · Cited by 1
Ingenhoven, T., & Rinne, T. (2007) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6404-6_18 · Cited by 1
Movement disorders in psychiatry as symptom, as side effect, and as risk factor
Willems, A. E. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231109aw · Cited by 1
The assessment and treatment of violence in personality disordered offenders
Thompson, C. L. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-24903-7.10019-8
Vestin, N., & María, A. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Empfehlung zur pharmakologischen Behandlung von Borderline-Persönlichkeitsstörungen
Lieb, K., & Stoffers-Winterling, J. M. (2014) · Ärztliche Psychotherapie und Psychosomatische Medizin
Carvajal, A., Arias, L. H. M., & Bulnes, N. J. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29006-8
Mircoli, G., Bascioni, S., Lucarelli, C., & Bellantuono, C. (2010) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2009.11.005
14 Werkzaamheid en werkzame factoren van psychotherapie
Verheul, R. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6821-1_14
Persönlichkeitsstörungen (F60, F61)
Romanos, M., & Wewetzer, C. (2009) · Springer eBooks · doi:10.1007/978-3-211-79275-9_25
Guideline Development Group Membership
Tyrer, P. J., Kendall, T., BATEMAN, A. W., Psychiatrist, C., Bayliss, L., & Bouras, N. (2005)
Overview of the treatment for borderline personality disorder
Veerasamy, K., & Guruvaiah, L. (2013)
Millet, B., Vanelle, J., & Benyaya, J. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-01922-7.00028-9
Caracterización del Trastorno Límite de la Personalidad y efectos del entrenamiento en mindfulness
Feliu‐Soler, A. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50021-6
Werkzaamheid en werkzame factoren van psychotherapie
Verheul, R. (2007) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6404-6_13
Borderline-Persönlichkeitsstörungen (ICD-10 F6)
Bohus, M., & Lieb, K. (2006) · Elsevier eBooks · doi:10.1016/b978-343724130-7.50017-1
KAPITEL 21 – Psychotherapie bei Persönlichkeitsstörungen
Doering, S., Sachse, R., Habermeyer, V., Rudolf, G., Herpertz, S., & Renneberg, B. (2008) · Elsevier eBooks · doi:10.1016/b978-343723730-0.50024-0
Aggression, Impulsivity, and Personality Disorders
Siever, L. J., & Kuluva, J. E. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195389715.013.0030
Pharmacologic interventions for antagonism and related disorders
Johnson, A. C. L., Wichser, L. M. H., & Nelson, K. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814627-9.00026-8
Ruminjo, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/sxw0-fj35
Psychopharmacologie du trouble de la personnalité borderline
Perroud, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76266-6.00010-0
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2006) · Elsevier eBooks · doi:10.1016/b978-343724130-7.50016-x
Millet, B., Vanelle, J., & Benyaya, J. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-74176-0.00030-1
Current awareness in human psychopharmacology
(2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.727
Herpertz, S. C., Habermeyer, V., & Bronisch, T. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_66
(2013) · CRC Press eBooks · doi:10.1201/b15462-35
Romanos, M., Wewetzer, C., & Schmeck, K. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_22
Patient M: Considerations for use of atypical antipsychotics in borderline personality disorder
Gay, T. L. (2010) · Personality and Mental Health · doi:10.1002/pmh.133
Metadata
- Authors
- Soler, J., Pascual, J. C., Campins, J., Barrachina, J., Puigdemont, D., Alvarez, E., & Pérez, V.
- Affiliations
- Hospital de Sant Pau (ES)
- Venue
- American Journal of Psychiatry
- Published
- 2005-06-01
- Volume
- 162
- Issue
- 6
- Pages
- 1221-1224
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2149470409
- Cited by
- 224
- References
- 6
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 10 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 2 · 2017: 12 · 2016: 9 · 2015: 6 · 2014: 13 · 2013: 10 · 2012: 18
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- borderline personality disorder, dialectical behavior therapy, olanzapine, combined psychotherapy and pharmacotherapy, depression, anxiety, impulsivity, aggression, treatment discontinuation
- MeSH terms
- Olanzapine, Adult, Behavior Therapy, Benzodiazepines, Borderline Personality Disorder, Combined Modality Therapy, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Placebos, Antipsychotic Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review